Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Quality and reliability of semaglutide-related health information on Chinese short-video platforms: a cross-sectional study of Bilibili and TikTok
Frontiers in public health, 2026;14:1826485
Renal Effects of Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Disease: A Narrative Review of Mechanisms and Clinical Evidence
Medicina (Kaunas, Lithuania), 2026;62(8)
Physical Activity Patterns in Adults Taking Glucagon-Like Peptide 1 Receptor Agonists: An All of Us Cross-sectional Study
Diabetes, obesity, and cardiometabolic CARE, 2026;1(5):823-830
In alcohol use disorder and comorbid obesity, weekly semaglutide reduced heavy drinking days at 26 wk
Annals of internal medicine, 2026
AgRP neurons are required for the weight-lowering effects of GLP-1 receptor agonists in female mice
Proceedings of the National Academy of Sciences of the United States of America, 2026;123(32):e2614476123
Resmetirom and semaglutide: next-generation therapies for metabolic-associated steatohepatitis. Opportunities, challenges and issues
Expert review of endocrinology & metabolism, 2026;:1-12
GLP-1 Receptor Agonist Therapy for Obesity Under Japan’s Optimal Use Guideline: A Prospective Real-World Study of Lifestyle Pre-Treatment, Time-Limited Treatment Cap, and Post-Cessation Regain
Diabetes, obesity & metabolism, 2026
Safety and efficacy of glucagon like peptide-1 receptor agonism-based therapies in end-stage renal disease: A systematic review and meta-analysis
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026
Confluent and reticulated papillomatosis improvement with tirzepatide-associated weight loss: A case report
JAAD case reports, 2026;76:41-43
Acute pancreatitis following semaglutide therapy: a case report
Annals of medicine and surgery (2012), 2026;88(9):6164-6166
Semaglutide in Practice: Insights from a Retrospective Case Series at a Jharkhand Tertiary Care Hospital
The Journal of the Association of Physicians of India;74(6):74-77
Real-World Use of Subsidised Semaglutide in Icelandic Children With Obesity: A Nationwide Retrospective Cohort Study
Pediatric obesity;21(8):e70139
Glucagon Agonist Therapies and Vision Loss: Balancing Promise with Prudence in India
The Journal of the Association of Physicians of India;74(6):94-96
GLP-1 receptor agonists in hip, knee and shoulder arthroplasty: Implications for obesity, osteoarthritis, metabolic optimisation and complications
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2026
Development and validation of a sensitive HPLC-MS/MS method for the analysis of semaglutide in human plasma
Bioanalysis, 2026;:1-10
Protecting Musculoskeletal Development and Physical Function in Adolescents on GLP-1 Therapy
Childhood obesity (Print), 2026;:21532176261475103
Trends in GLP-1 Receptor Agonist Prescribing Without Documented Indications
Diabetes, obesity & metabolism, 2026
Overweight and obesity induce Toll-like receptor 2-induced Type I IFN signaling
npj metabolic health and disease, 2026;4(1)
Peripheral nerve complications from medications utilised for weight loss: a systematic review
Journal of neurology, 2026;273(8)
Semaglutide-associated NAION: a proposed ‘two-hit’ model involving buried optic disc drusen and sustained hypohydration
The British journal of ophthalmology, 2026